A detailed history of Prudential Financial Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 161,280 shares of ANNX stock, worth $851,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161,280
Previous 39,340 309.96%
Holding current value
$851,558
Previous $192,000 396.88%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.49 - $7.2 $547,510 - $877,968
121,940 Added 309.96%
161,280 $954,000
Q2 2024

Aug 13, 2024

BUY
$4.33 - $6.79 $9,590 - $15,039
2,215 Added 5.97%
39,340 $192,000
Q1 2024

May 14, 2024

SELL
$4.03 - $7.81 $175,224 - $339,578
-43,480 Reduced 53.94%
37,125 $266,000
Q4 2023

Feb 13, 2024

SELL
$1.63 - $4.63 $150,286 - $426,886
-92,200 Reduced 53.35%
80,605 $365,000
Q3 2023

Nov 13, 2023

BUY
$2.13 - $3.84 $368,074 - $663,571
172,805 New
172,805 $407,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $251M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.